• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Activin Signal Transduction in Cell Growth, Differentiation and Apoptosis

Research Project

Project/Area Number 08458199
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Functional biochemistry
Research InstitutionUniversity of Tokushima

Principal Investigator

SUGINO Hiromu  University of Tokushima, The Institute for Enzyme Research, Professor, 分子酵素学研究センター, 教授 (50211305)

Co-Investigator(Kenkyū-buntansha) SHOJI Hiroki  Kagawa Medical University, Research Associate, 助手 (10263873)
NAKAMURA Takanori  Kagawa Medical University, Professor, 教授 (70183887)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥6,600,000 (Direct Cost: ¥6,600,000)
Fiscal Year 1997: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1996: ¥4,800,000 (Direct Cost: ¥4,800,000)
Keywordsactivin / TGF-beta / differentiation / growth / apoptosis / cell-cycle / heparan sulfate / 細胞内情報伝達 / 増殖 / 分化 / 受容体 / シグナル伝達 / α-フォドリン / 2-ハイブリッドシステム
Research Abstract

Activin belonging to the TGF-beta superfamily binds to and signals through a receptor complex comprising two transmembrane serine/threonine kinases, called type I and type II.So far, two type II (ActR-IIA,-IIB) and two type I (ActR-IA,IB) activin receptors have been cloned from mammalian sources. In this study, we attempted to elucidate the role of type I receptors in activin signaling for growth, differentiation and apoptosis, and obtained following results.
(1) We established stable HS-72 transfectants overexpressing ActR-IA or ActR-IB by the electroporation procedure. Overexpression of ActR-IA suppressed activin-induced cell-cycle arrest in the G1 phase caused by inhibition of retinoblastoma protein phosphorylation through induction of p21, a cyclin-dependent kinase inhibitor, and subsequent apoptosis. In contrast, HS-72 clones that overexpressed ACtR-IB significantly facilitated activin induced apoptosis. These results indicate that ActR-IA and ActR-IB are distinct from each other in activin signal transduction.
(2) Significant degradation of a cytoskeleton, alpha-fodrin was observed upon activin-induced apoptosis in HS-72 cells. Overexpression of ActR-IA in HS-72 cells caused prevention of the alpha-fodrin degradation, suggesting that the apoptotic signal of activin in relevant to the proteolytic degradation of alpha-fodrin.
(3) Follistatin (activin-binding protein) was found to promote the binding of activin to cell surface heparan sulfate. When the cells were incubated with ^<125>I-activin in the presence of follistatin, significant degradation of activin was observed. This activin degradation was abolished by heparan sulfate, chloroquine, and lysosomal protease inhibitors. These results indicate that cell-associated follistatin accelerates the uptake of activin into cells, leading to increased degradation by lysosomal enzymes, and thus plays a role in the activin clearance system.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (28 results)

All Other

All Publications (28 results)

  • [Publications] Johan P.de Winter: "Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type I receptors" Exp.Cell.Res.224. 323-334 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Koji Okabayashi: "cDNA cloning and expression of the Xenopus laevis vitellogenin receptor" Biochem.Biophys.Res.Commun.224. 406-413 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Johan P.de Winter: "Follistatin neutralize activin bioactibity by inhibition of activin binding to its type II receptors" Molec.Cell.Endocrinol.116. 105-114 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Jun′ichi Mashimo: "Decrease in the expression of a novel TGF β1-inducible and ras-recision gene,TSC-36,in human cancer cells" Cancer Letters.113. 213-219 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Norio Haneji: "Identification of α-fodrin as a candidate autoantigen in primary Sjogren′s syndrome" Science. 276. 604-607 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Osamu Hashimoto: "A novel role of follistatin,an activin-binding protein,in the inhibition of activin action in rat pituitary cells" J.Biol.Chem.272. 13835-13842 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hiromu Sugino: "Follistatin and its role as an activin-binding protein" The Journal of Medical Investigation. 44. 1-14 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 杉野 弘: "生化学" 日本生化学会, 24 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Johan P.de Winter: "Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type I receptors" Exp.Cell.Res.224. 323-334 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Koji Okabayashi: "cDNA cloning and expression of the Xenopus laevis vitellogenin receptor" Bichem.Biophys.Res.Commun.224. 406-413 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Johan P.de Winter: "Follistatin neutralize activin bioactibity by inhibition of activin binding to its type II receptors" Molec.Cell.Endocrinol.116. 105-114 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Jun'ichi Mashimo: "Decrease in the expression of a novel TGF beta1-inducible and ros-recision gene, TSC-36, in human cancer cells" Cancer Letters. 113. 213-219 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Norio Haneji: "Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome" Science. 276. 604-607 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Osamu Hashimoto: "A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells" J.Biol.Chem.272. 13835-13842 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hiromu Sugino: "Follistatin and its role as a activin-bindingprotein" The Journal of Medical Investigation. 44. 1-14 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hiromu Sugino: Activin : Diversity of functions and signal transduction. The Japanese Biochemical Society, 24 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Johan P.de Winter: "Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type I receptors" Exp.Cell.Res.224. 323-334 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Koji Okabayashi: "cDNA cloning and expression of the Xenopus laevis vitellogenin receptor" Biochem.Biophys.Res.Commun.224. 406-413 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Johan P.de Winter: "Follistatin neutralize activin bioactibity by inhibition of activin binding to its type II receptors" Molec.Cell.Endocrinol.116. 105-114 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Jun'ichi Mashimo: "Decrease in the expression of a novel TGF β1-inducible and ras-recision gene,TSC-36,in human cancer cells" Cancer Letters.113. 213-219 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Norio Haneji: "Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome" Science. 276. 604-607 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Osamu Hashimoto: "A novel role of follistatin,an activin-binding protein,in the inhibition of activin action in rat pituitary cells" J.Biol.Chem.272. 13835-13842 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hiromu Sugino: "Follistatin and its role as an activin-binding protein" The Journal of Medical Investigation. 44. 1-14 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 杉野 弘: "生化学" 日本生化学会, 24 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] 杉野 弘: "発生と成長因子・ホルモン" 日本比較内分泌学会, 20 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Koji Okabayashi: "cDNA Cloning and Expression of the Xenopus Laevis Vitellogenin Receptor" Biochem.Biophys.Res.Commun.224. 406-413 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Johan P.de Winter: "Follistatins Neutralize Activin Bioactivity by Inhibition of Activin Binding to Its Type II Receptors" Molec.Cell.Endocrinol.116. 105-114 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Osamu Hashimoto: "A Novel Role of Follistatin,an Activin-Binding Protein,in the Inhibition of Activin Action in Rat Pituitary Cells" J.Biol.Chem.(in press). (1997)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi